The first pilot rapid assessment on ‘Zostavax for the prevention herpes zoster’
The purpose of the assessment is to evaluate Zostavax® for the prevention of herpes zoster. Final version of the assessment was published in September 2013 Below is the documentation provided by the Joint Assessment authoring team: Zostavax for prevention of herpes zoster and postherpetic neuralgia_Rapid REA_Final_Sep 2013_0.pdf
List of comments for the WP5 JA1 Pilot Pazopanib Report
The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their contributions. The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their contributions. This document is […]
WP5 Strand B – Procedure Manual V3
This document describes processes planned for conducting pilot rapid assessments for other technologies such as medical devices, surgical interventions or diagnostics. Since the Procedure Manual is a living document, further changes can be expected due to experiences gathered throughout JA2. Procedure Manual V3.pdf
